Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Treasury Shares: 2014-2024

Historic Treasury Shares for OptimizeRx (OPRX) over the last 3 years, with FY2024 value amounting to $2000.0.

  • OptimizeRx's Treasury Shares changed 0.0% to $2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $2000.0 for FY2024, which is 0.0% changed from last year.
  • OptimizeRx's Treasury Shares amounted to $1.7 million in FY2024, which was down 0.0% from $1.7 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Treasury Shares ranged from a high of $1.7 million in FY2023 and a low of $789074.0 during FY2022
  • Moreover, its 4-year median value for Treasury Shares was $1.5 million (2021), whereas its average is $1.4 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 6474.46% in 2023, then changed by 0.0% in 2024.
  • Over the past 3 years, OptimizeRx's Treasury Shares (Annual) stood at $1214.0 in 2022, then surged by 64.74% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024.
  • Its last three reported values are $2000.0 in FY2024, $2000.0 for FY2023, and $1214.0 during FY2022.